| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |